2-methylthio-atp has been researched along with 6-ketoprostaglandin f1 alpha in 1 studies
Studies (2-methylthio-atp) | Trials (2-methylthio-atp) | Recent Studies (post-2010) (2-methylthio-atp) | Studies (6-ketoprostaglandin f1 alpha) | Trials (6-ketoprostaglandin f1 alpha) | Recent Studies (post-2010) (6-ketoprostaglandin f1 alpha) |
---|---|---|---|---|---|
265 | 0 | 16 | 4,832 | 294 | 150 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 1 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Boarder, MR; Bowden, A; Brown, CA; Patel, V | 1 |
1 other study(ies) available for 2-methylthio-atp and 6-ketoprostaglandin f1 alpha
Article | Year |
---|---|
Stimulation of prostacyclin release by endothelial ATP receptors requires activation of protein kinase C and tyrosine kinases.
Topics: 6-Ketoprostaglandin F1 alpha; Adenosine Triphosphate; Animals; Aorta; Blotting, Western; Cattle; Cells, Cultured; Endothelium, Vascular; Enzyme Activation; Enzyme Inhibitors; Epoprostenol; Phosphotyrosine; Protein Kinase C; Protein-Tyrosine Kinases; Purinergic P2 Receptor Agonists; Receptors, Purinergic P2; Thionucleotides; Uridine Triphosphate | 1996 |